Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

Phase 2
2(50.0%)
N/A
2(50.0%)
4Total
Phase 2(2)
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06513026Not ApplicableRecruiting

Milk for Diabetes Prevention

Role: collaborator

NCT06329544Not ApplicableRecruiting

High Fructose Diet, the Gut Microbiome, and Metabolic Health

Role: collaborator

NCT01323582Phase 2Terminated

Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis

Role: collaborator

NCT01674088Completed

Sucrose Breath Test to Determine Intestinal Permeability in IBS

Role: lead

NCT01184573Completed

Novel Breath Test to Detect Early Stage Chronic Pancreatitis

Role: lead

NCT00628732Phase 2Completed

A Pharmacokinetic Study of Oral Cyclophosphamide and Topotecan in Children With Recurrent Solid Tumors

Role: collaborator

All 6 trials loaded